Skip Navigation and Go To Content

Executive Vice President & Chief Academic Officer

Limited Submissions

Current Limited Submission Opportunities (6)

CPRIT
Core Facility Support Awards (CFSA)
High-Impact/High-Risk Research Awards (HIHR)
Early Translational Research Awards
Collaborative Action Program to Reduce Liver Cancer Mortality in Texas: Collaborative Action Center Award

Ted Nash Long Life Foundation

note: the internal deadline for all programs listed above is Friday, September 21, 2018

Blavatnik National Awards for Young Scientists (internal deadline is Friday October 5, 2018)


Limited Submissions are grant opportunities that restrict the number of applications from qualified institutions. In these cases, UTHealth will post opportunities on this page as they become available and specify the requirements needed to launch an internal competition to select the university's applicant(s).

Michael R. Blackburn, PhD, Executive Vice President & Chief Academic Officer, will establish ad hoc internal review committees as needed based upon the nature of the RFA and the pre-applications received so as to ensure expertise and minimize conflicts of interest.

If an investigator identifies a limited opportunity that is not posted on this page, he or she should contact Deanne Hernandez via email to express interest. Opportunities are considered first-come, first-served if the sponsor deadline is less than two months' away. If the deadline is more than two months' away, an internal competition will launch.


OPEN INTERNAL COMPETITIONS


CPRIT Core Facility Support Awards (CFSA)

UTHealth is eligible to select one (1) proposal for submission in response to the CPRIT Core Facility Support Award RFA released on August 17, 2018. 

This RFA "solicits applications from institutions that establish or enhance core facilities (laboratory, clinical, population-based, or computer-based) that will directly support cancer research programs to advance knowledge of the causes, prevention, and/or treatment of cancer or improve quality of life for patients with and survivors of cancer."

UTHealth's selected proposal may fall under one of the three categories: new submission, re-submission (only allowed once), or renewal (if funding is scheduled to end in FY 2019). Pre-applications must note the category and are due no later than Friday, September 21, 2018, which will allow sufficient time for an internal review. The CPRIT online application system opens on October 17, 2018 and the submission deadline is January 30, 2019.

Pre-applications must contain:

Please submit all nominations electronically and as a single PDF file to Deanne Hernandez at Deanne.M.Hernandez@uth.tmc.edu under the title “2019 CPRIT Cores”.

Please go here for additional information on this award program: http://www.cprit.state.tx.us/images/uploads/rfa-r-192-cfsa-v2.pdf


CPRIT High-Impact/High-Risk Research Awards (HIHR)

UTHealth is eligible to select five (5) proposals for submission in response to the CPRIT High-Impact/High-Risk RFA released on August 17, 2018. 

"CPRIT High-Impact/High-Risk (HIHR) Research Awards seek to provide short-term funding to explore the feasibility of high-risk projects that, if successful, would contribute major new insights into the etiology, diagnosis, treatment, or prevention of cancers. Because HIHR Research Awards are designed to support new ideas, preliminary data are not required. Using this mechanism, CPRIT intends to support innovative, developmental projects that focus on exceptionally promising topics that are not yet sufficiently mature to compete successfully for more conventional funding. The HIHR Research Awards are expected to provide the foundation for individual or multiple investigator awards upon completion. Applicants must explain why more conventional sources of support are not available for the proposed research and how short-term funding will lead to strong applications for additional support."

Pre-applications are due no later than Friday, September 21, 2018, which will allow sufficient time for an internal review. The CPRIT online application system opens on October 17, 2018 and the submission deadline is January 30, 2019.

Pre-applications must contain:

Please submit all nominations electronically and as a single PDF file to Deanne Hernandez at Deanne.M.Hernandez@uth.tmc.edu under the title “2019 CPRIT HIHR”.

Please go here for additional information on this award program: http://www.cprit.state.tx.us/images/uploads/rfa-r-192-hihr-v2.pdf


CPRIT Early Translational Research Awards

UTHealth is eligible to select two (2) proposals for submission in response to the CPRIT Early Translational Research Award RFA released on August 17, 2018. 

"The ETRA is intended to bridge the gap between promising new discoveries achieved in the research laboratory and the commercial development of a therapeutic product, medical device, or diagnostic assay through activities up to and including preclinical proof-of-concept data that demonstrate applicability to the planned clinical scenario. The work funded under this RFA must be deemed sufficiently robust such that successful completion would result in a lead product that has compelling evidence of efficacy in qualified models, a favorable preliminary safety profile, and, for therapeutics, evidence of feasibility of scale-up and bulk synthesis. In other words, at the completion of the project it will be clear if the lead product under development has the attributes necessary to attract private investment to continue its development toward IND-enabling studies (IDE-enabling preclinical plan in the case of a medical device) and clinical evaluation"

Pre-applications are due no later than Friday, September 21, 2018, which will allow sufficient time for an internal review. The CPRIT online application system opens on October 17, 2018 and the submission deadline is January 30, 2019.

Pre-applications must contain:

Please submit all nominations electronically and as a single PDF file to Deanne Hernandez at Deanne.M.Hernandez@uth.tmc.edu under the title “2019 CPRIT ETRA”.

Please go here for additional information on this award program: http://www.cprit.state.tx.us/images/uploads/rfa-r-192-etra-v2.pdf


CPRIT Collaborative Action Program to Reduce Liver Cancer Mortality in Texas: Collaborative Action Center Award

UTHealth is eligible to select one (1) proposal for submission in response to the CPRIT Collaborative Action Center Award RFA released on August 17, 2018. 

"Applicants are invited to propose a Center whose functions will be to (1) promote interactions and collaboration across the CAP Research Awards funded under the companion RFA, R-19.2- CAP; RA (2) provide opportunities for academic content experts, health care providers, and community stakeholders to exchange ideas and to explore new opportunities to impact the rise of hepatocellular cancer (HCC) in Texas; and (3) educate health care providers and the public on best practices to alter the trajectory of HCC in Texas"

Pre-applications for the Collaborative Action Center Award are due no later than Friday, September 21, 2018, which will allow sufficient time for an internal review. The CPRIT online application system opens on October 17, 2018 and the submission deadline is January 30, 2019.

Pre-applications must contain:

Please submit all nominations electronically and as a single PDF file to Deanne Hernandez at Deanne.M.Hernandez@uth.tmc.edu under the title “2019 CPRIT CAC”.

Please go here for additional information on this award program: http://www.cprit.state.tx.us/images/uploads/rfa-r-192-cap_cac.pdf (institutional limit = 1) and here for information on the companion Investigator-initiated Research Awards: http://www.cprit.state.tx.us/images/uploads/rfa-r-192-cap_ra.pdf (no institutional limit)


Ted Nash Long Life Foundation

McGovern Medical School was invited to submit two (2) grant applications to the Ted Nash Long Life Foundation, whose aim is to “support medical research at the Mayo Clinic and at seven medical schools within the State of Texas with the hope that the results of the research will eventually extend the life expectancy of the average American.”

Eligible applicants must be a regular, full-time tenured or tenure track faculty member at McGovern Medical School.

Pre-applications are due no later than Friday, September 21, 2018, to allow sufficient time for an internal review should one be necessary. The submission deadline is October 15, 2018.

Pre-applications must contain:

Please submit all nominations electronically and as a single PDF file to Deanne Hernandez at Deanne.M.Hernandez@uth.tmc.edu under the title “Ted Nash Long Life Foundation.” Please click here for more information.


Blavatnik National Awards for Young Scientists

UTHealth was invited to nominate up to three young investigators (one in each disciplinary category of Life Sciences, Physical Sciences & Engineering, and Chemistry) for the 2019 Blavatnik National Awards for Young Scientists. The Blavatnik National Awards “recognize excellence in three disciplinary categories: Life Sciences; Physical Sciences & Engineering; and Chemistry. Every year, one Blavatnik Laureate in each category will receive $250,000 in unrestricted funds. The prize money is given directly to the Laureate."

Eligible nominees must:


Nominees and their work as independent investigators will be evaluated according to the following criteria:


Additional information on the Blavatnik Awards Program, including guidelines and FAQs, is available here

Nominations must note the discipline and are due no later than Friday, October 5, 2018, which will allow sufficient time for an internal review should one be necessary. The Blavatnik online nomination submission deadline is November 14, 2018 and letters of support are due by November 28, 2018.

Pre-applications must contain:

Please submit all nominations electronically and as a single PDF file to Deanne Hernandez at Deanne.M.Hernandez@uth.tmc.edu under the title “Blavatnik National Awards”.

Please go here for additional information on this award program: http://blavatnikawards.org/awards/national-awards/